<!–:en–>AEMPS: Informes de Posicionamiento Terapéutico "brentuximab (Adcetris®), eculizumab (Soliris®) y pazopanib (Votrient®)"<!–:–><!–:es–>AEMPS: Informes de Posicionamiento Terapéutico "brentuximab (Adcetris®), eculizumab (Soliris®) y pazopanib (Votrient®)"<!–:–>

Sorry, this entry is only available in European Spanish. For the sake of viewer convenience, the content is shown below in the alternative language. You may click the link to switch the active language.

Con fecha 27 de noviembre de 2014, la AEMPS publica los siguientes Informes de posicionamiento terapéutico:

• 
  (PT-BRENTUXIMAB/V1/19112014)

• 
  (PT-PAZOPANIB-SARCOMA/V1/19112014)

• 
  (PT/V1/19112014)

 

 

Posted on the AEMPS website on 27 November 2014